The immune response during hepatitis B virus infection

Journal of General Virology

Volumn 87, Issue 6, 2006, Pages 1439-1449

  Bertoletti, Antonio ^a   Gehring, Adam J ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B(E) ANTIGEN; VIRUS ANTIGEN;

CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHRONIC HEPATITIS; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; INFECTION CONTROL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; NONHUMAN; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; REVIEW; VIRUS CELL INTERACTION; VIRUS IMMUNITY; VIRUS LOAD; VIRUS REPLICATION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; IMMUNITY, NATURAL; MICE;

HEPATITIS B VIRUS;

EID: 33744808242     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.81920-0     Document Type: Review

References (114)

1. + T cell population in chronic hepatitis C virus infection. J Clin Invest 113, 963-972.
2. Alberti, A., Diana, S., Sculard, G. H., Eddleston, A. L. & Williams, R. (1978). Detection of a new antibody system reacting with Dane particles in hepatitis B virus infection. Br Med J 2, 1056-1058.
3. Alberti, A., Chemello, L. & Benvegnu, L. (1999). Natural history of hepatitis C. J Hepatol 31, S17-S24.
4. Alexopoulou, L., Holt A. C., Medzhitov, R. & Flavell, R. A. (2001). Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 413, 732-738.
5. Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y. J., Pulendran, B. & Palucka, K. (2000). Immunobiology of dendritic cells. Annu Rev Immunol 18, 767-811.
6. Baron, J. L., Gardiner, L., Nishimura, S., Shinkai, K., Locksley, R. & Ganem, D. (2002). Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection. Immunity 16, 583-594.
7. Beckebaum, S., Cicinnati, V. R., Dworacki, G. & 8 other authors (2002). Reduction in the circulating pDC1/pDC2 ratio and impaired function of ex vivo-generated DC1 in chronic hepatitis B infection. Clin Immunol 104, 138-150.
8. Berquist K. R., Peterson, J. M., Murphy, B. L., Ebert J. W., Maynard, J. E. & Purcell, R. H. (1975). Hepatitis B antigens in serum and liver of chimpanzees acutely infected with hepatitis B virus. Infect Immun 12, 602-605.
9. Bertoletti, A. & Ferrari, C. (2003). Kinetics of the immune response during HBV and HCV infection. Hepatology 38, 4-13.
10. Bertoletti, A., Ferrari, C., Fiaccadori, F., Penna, A., Margolskee, R., Schlicht H. J., Fowler, P., Guilhot, S. & Chisari, F. V. (1991). HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen. Proc Natl Acad Sci U S A 88, 10445-10449.
11. Bertoletti, A., Costanzo, A., Chisari, F. V. & 7 other authors (1994). Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope. J Exp Med 180, 933-943.
12. Bertoletti, A., Southwood, S., Chesnut R. & 7 other authors (1997). Molecular features of the hepatitis B virus nucleocapsid T-cell epitope 18-27: interaction with HLA and T-cell receptor. Hepatology 26, 1027-1034.
13. + T lymphocytes but fail to promote survival. Eur J Immunol 28, 221-236.
14. + T cells within the liver. J Immunol 166, 5430-5438.
15. Bertoni, R., Sidney, J., Fowler, P., Chesnut, R. W., Chisari, F. V. & Sette, A. (1997). Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis. J Clin Invest 100, 503-513.
16. Bigger, C. B., Brasky, K. M. & Lanford, R. E. (2001). DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection. J Virol 75, 7059-7066.
17. Biron, C. A. (2001). Interferons alpha and beta as immune regulators - a new look. Immunity 14, 661-664.
18. +-T-lymphocyte responses. J Virol 78, 2247-2254.
19. Bocher, W. O., Herzog-Hauff, S., Schlaak, J., Meyer zum Buschenfeld, K. H. & Lohr, H. F. (1999). Kinetics of hepatitis B surface antigen-specific immune responses in acute and chronic hepatitis B or after HBs vaccination: stimulation of the in vitro antibody response by interferon gamma. Hepatology 29, 238-244.
20. Boni, C., Penna, A., Ogg, G. S. & 9 other authors (2001). Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy. Hepatology 33, 963-971.
21. Boni, C., Penna, A., Bertoletti, A. & 10 other authors (2003). Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B. J Hepatol 39, 595-605.
22. Bowen, D. G., Zen, M., Holz, L., Davis, T., McCaughan, G. W. & Bertolino, P. (2004). The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity. J Clin Invest 114, 701-712.
23. Brunetto, M. R., Giarin, M. M., Oliveri, F. & 8 other authors (1991). Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis. Proc Natl Acad Sci U S A 88, 4186-4190.
24. Celis, E., Ou, D. & Otvos, L., Jr (1988). Recognition of hepatitis B surface antigen by human T lymphocytes. Proliferative and cytotoxic responses to a major antigenic determinant defined by synthetic peptides. J Immunol 140, 1808-1815.
25. + T-cell responses in human immunodeficiency virus type 1-HBV-coinfected individuals receiving HBV-active antiretroviral therapy. J Virol 79, 3038-3051.
26. Chen, M. T., Billaud, J. N., Sallberg, M., Guidotti, L. G., Chisari, F. V., Jones, J., Hughes, J. & Milich, D. R. (2004). A function of the hepatitis B virus precore protein is to regulate the immune response to the core antigen. Proc Natl Acad Sci U S A 101, 14913-14918.
27. Chen, M., Sallberg, M., Hughes, J., Jones, J., Guidotti, L. G., Chisari, F. V., Billaud, J. N. & Milich, D. R. (2005). Immune tolerance split between hepatitis B virus precore and core proteins. J Virol 79, 3016-3027.
28. Chisari, F. V. & Ferrari, C. (1995). Hepatitis B virus immunopathogenesis. Annu Rev Immunol 13, 29-60.
29. + T cell responses during chronic virus infection prevents neutralizing antibody responses against virus escape mutants. J Exp Med 193, 297-305.
30. Coffin, C. S. & Michalak, T. I. (1999). Persistence of infectious hepadnavirus in the offspring of woodchuck mothers recovered from viral hepatitis. J Clin Invest 104, 203-212.
31. Cote, P. J., Toshkov, I., Bellezza, C. & 9 other authors (2000). Temporal pathogenesis of experimental neonatal woodchuck hepatitis virus infection: increased initial viral load and decreased severity of acute hepatitis during the development of chronic viral infection. Hepatology 32, 807-817.
32. Crispe, I. N., Dao, T., Klugewitz, K., Mahal, W. Z. & Metz, D. P. (2000). The liver as a site of T-cell apoptosis: graveyard, or killing field? Immunol Rev 174, 47-62.
33. Ferrari, C., Penna, A., Bertoletti, A., Cavalli, A., Valli, A., Schianchi, C. & Fiaccadori, F. (1989). The preS1 antigen of hepatitis B virus is highly immunogenic at the T cell level in man. J Clin Invest 84, 1314-1319.
34. Ferrari, C., Penna, A., Bertoletti, A., Valli, A., Antoni, A. D., Giuberti, T., Cavalli, A., Petit, M. A. & Fiaccadori, F. (1990). Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J Immunol 145, 3442-3449.
35. Ferrari, C., Bertoletti, A., Penna, A. & 8 other authors (1991). Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen. J Clin Invest 88, 214-222.
36. Fong, T. L., Di Bisceglie, A. M., Biswas, R., Waggoner, J. G., Wilson, L., Claggett, J. & Hoofnagle, J. H. (1994). High levels of viral replication during acute hepatitis B infection predict progression to chronicity. J Med Virol 43, 155-158.
37. + regulatory T cells in patients with hepatitis B virus infection. J Virol 79, 3322-3328.
38. Gallimore, A., Dumrese, T., Hengartner, H., Zinkernagel, R. M. & Rammensee, H. G. (1998). Protective immunity does not correlate with the hierarchy of virus-specific cytotoxic T cell responses to naturally processed peptides. J Exp Med 187, 1647-1657.
39. Ganem, D. & Prince, A. M. (2004). Hepatitis B virus infection - natural history and clinical consequences. N Engl J Med 350, 1118-1129.
40. Grady, G. F., Lee, V. A., Prince, A. M. & 14 other authors (1978). Hepatitis B immune globulin for accidental exposures among medical personnel: final report of a multicenter controlled trial. J Infect Dis 138, 625-638.
41. Guidotti, L. G. & Chisari, F. V. (1996). To kill or to cure: options in host defense against viral infection. Curr Opin Immunol 8, 478-483.
42. Guidotti, L. G. & Chisari, F. V. (2001). Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 19, 65-91.
43. Guidotti, L. G., Rochford, R., Chung, J., Shapiro, M., Purcell, R. & Chisari, F. V. (1999). Viral clearance without destruction of infected cells during acute HBV infection. Science 284, 825-829.
44. Hell, F., Hemmi, H., Hochrein, H., Ampenberger, F., Kirschning, C., Akira, S., Lipford, G., Wagner, H. & Bauer, S. (2004). Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303, 1526-1529.
45. Hodgson, P. D. & Michalak T. I. (2001). Augmented hepatic interferon gamma expression and T-cell influx characterize acute hepatitis progressing to recovery and residual lifelong virus persistence in experimental adult woodchuck hepatitis virus infection. Hepatology 34, 1049-1059.
46. Hwang, Y. K, Kim, N. K., Park J. M., Lee, K., Han, W. K., Kim, H. I. & Cheong, H. S. (2002). HLA-A2 1 restricted peptides from the HBx antigen induce specific CTL responses in vitro and in vivo. Vaccine 20, 3770-3777.
47. Hyodo, N., Nakamura, I. & Imawari, M. (2004). Hepatitis B core antigen stimulates interleukin-10 secretion by both T cells and monocytes from peripheral blood of patients with chronic hepatitis B virus infection. Clin Exp Immunol 135, 462-466.
48. + T cell effector functions after antigen recognition in the liver. Immunity 23, 53-63.
49. Iwarson, S., Wahl, M., Ruttimann, E., Snoy, P., Seto, B. & Gerety, R. J. (1988). Successful postexposure vaccination against hepatitis B in chimpanzees. J Med Virol 25, 433-439.
50. Jilbert A. R., Wu, T. T., England, J. M., Hall, P. M., Carp, N. Z., O'Connell, A. P. & Mason, W. S. (1992). Rapid resolution of duck hepatitis B virus infections occurs after massive hepatocellular involvement. J Virol 66, 1377-1388.
51. Jung, M. C., Spengler, U., Schraut, W. & 8 other authors (1991). Hepatitis B virus antigen-specific T-cell activation in patients with acute and chronic hepatitis B. J Hepatol 13, 310-317.
52. Jung, M. C., Hartmann, B., Gerlach, J. T. & 9 other authors (1999). Virus-specific lymphokine production differs quantitatively but not qualitatively in acute and chronic hepatitis B infection. Virology 261, 165-172.
53. Kafrouni, M. I., Brown, G. R. & Thiele, D. L. (2001). Virally infected hepatocytes are resistant to perforin-dependent CTL effector mechanisms. J Immunol 167, 1566-1574.
54. Kajino, K, Jilbert A. R., Saputelli, J., Aldrich, C. E. Cullen, J. & Mason, W. S. (1994). Woodchuck hepatitis virus infections: very rapid recovery after a prolonged viremia and infection of virtually every hepatocyte. J Virol 68, 5792-5803.
55. Kakimi, K., Guidotti, L. G., Koezuka, Y. & Chisari, F. V. (2000). Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J Exp Med 192, 921-930.
56. Kakimi, K, Lane, T. E, Chisari, F. V. & Guidotti, L. G. (2001). Cutting edge: inhibition of hepatitis B virus replication by activated NK T cells does not require inflammatory cell recruitment to the liver. J Immunol 167, 6701-6705.
57. Kakimi, K., Isogawa, M., Chung, J., Sette, A. & Chisari, F. V. (2002). Immunogenicity and tolerogenicity of hepatitis B virus structural and nonstructural proteins: implications for immunotherapy of persistent viral infections. J Virol 76, 8609-8620.
58. Kalams, S. A. & Walker, B. D. (1998). The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses. J Exp Med 188, 2199-2204.
59. + T cells activated locally within the transplanted liver. J Exp Med 203, 437-447.
60. Korba, B. E., Cote, P. J., Wells, F. V., Baldwin, B., Popper, H., Purcell, R. H., Tennant B. C. & Gerin, J. L. (1989). Natural history of woodchuck hepatitis virus infections during the course of experimental viral infection: molecular virologic features of the liver and lymphoid tissues. J Virol 63, 1360-1370.
61. Lew, Y. Y. & Michalak, T. I. (2001). In vitro and in vivo infectivity and pathogenicity of the lymphoid cell-derived woodchuck hepatitis virus. J Virol 75, 1770-1782.
62. Lohr, H. F., Pingel, S., Bocher, W. O., Bernhard, H., Herzog-Hauff, S., Rose-John, S. & Galle, P. R. (2002). Reduced virus specific T helper cell induction by autologous dendritic cells in patients with chronic hepatitis B - restoration by exogenous interleukin-12. Clin Exp Immunol 130, 107-114.
63. Lok, A. S. & McMahon, B. J. (2001). Chronic hepatitis B. Hepatology 34, 1225-1241.
64. Lund, J., Sato, A., Akira, S., Medzhitov, R. & Iwasaki, A. (2003). Toll-like receptor 9-mediated recognition of herpes simplex virus-2 by plasmacytoid dendritic cells. J Exp Med 198, 513-520.
65. + T cells associated with the control of infection. Gastroenterology 117, 1386-1396.
66. + cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med 191, 1269-1280.
67. Maloy, K. J. & Powrie, F. (2001). Regulatory T cells in the control of immune pathology. Nat Immunol 2, 816-822.
68. McClary, H., Koch, R., Chisari, F. V. & Guidotti, L. G. (2000). Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines. J Virol 74, 2255-2264.
69. Menne, S., Roneker, C. A., Roggendorf, M., Gerin, J. L., Cote, P. J. & Tennant B. C. (2002). Deficiencies in the acute-phase cell-mediated immune response to viral antigens are associated with development of chronic woodchuck hepatitis virus infection following neonatal inoculation. J Virol 76, 1769-1780.
70. Milich, D. & Liang, T. J. (2003). Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infection. Hepatology 38, 1075-1086.
71. Milich, D. R., Jones, J. E., Hughes, J. L., Price, J., Raney, A. K. & McLachlan, A. (1990). Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero? Proc Natl Acad Sci U S A 87, 6599-6603.
72. Milich, D. R., Chen, M. K., Hughes, J. L. & Jones, J. E. (1998). The secreted hepatitis B precore antigen can modulate the immune response to the nucleocapsid: a mechanism for persistence. J Immunol 160, 2013-2021.
73. Missale, G., Redeker, A., Person, J., Fowler, P., Guilhot, S., Schlicht H. J., Ferrari, C. & Chisari, F. V. (1993). HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis. J Exp Med 177, 751-762.
74. Mizukoshi, E., Sidney, J., Livingston, B., Ghany, M., Hoofnagle, J. H., Sette, A. & Rehermann, B. (2004). Cellular immune responses to the hepatitis B virus polymerase. J Immunol 173, 5863-5871.
75. Moretta, L., Bottino, C., Pende, D., Vitale, M., Mingari, M. C. & Moretta, A. (2005). Human natural killer cells: molecular mechanisms controlling NK cell activation and tumor cell lysis. Immunol Lett 100, 7-13.
76. Nakamura, I., Nupp, J. T., Cowlen, M., Hall, W. C., Tennant, B. C., Casey, J. L., Gerin, J. L. & Cote, P. J. (2001). Pathogenesis of experimental neonatal woodchuck hepatitis virus infection: chronicity as an outcome of infection is associated with a diminished acute hepatitis that is temporally deficient for the expression of interferon gamma and tumor necrosis factor-alpha messenger RNAs. Hepatology 33, 439-447.
77. Nayersina, R., Fowler, P., Guilhot, S. & 7 other authors (1993). HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. J Immunol 150, 4659-4671.
78. Ou, R., Zhou, S., Huang, L. & Moskophidis, D. (2001). Critical role for alpha/beta and gamma interferons in persistence of lymphocytic choriomeningitis virus by clonal exhaustion of cytotoxic T cells. J Virol 75, 8407-8423.
79. Penna, A., Chisari, F. V., Bertoletti, A., Missale, G., Fowler, P., Giuberti, T., Fiaccadori, F. & Ferrari, C. (1991). Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen. J Exp Med 174, 1565-1570.
80. Penna, A., Artini, M., Cavalli, A. & 8 other authors (1996). Long-lasting memory T cell responses following self-limited acute hepatitis B. J Clin Invest 98, 1185-1194.
81. Penna, A., Del Prete, G., Cavalli, A. & 8 other authors (1997). Predominant T-helper 1 cytokine profile of hepatitis B virus nucleocapsid-specific T cells in acute self-limited hepatitis B. Hepatology 25, 1022-1027.
82. Rehermann, B., Pasquinelli, C., Mosier, S. M. & Chisari, F. V. (1995a). Hepatitis B virus (HBV) sequence variation of cytotoxic T lymphocyte epitopes is not common in patients with chronic HBV infection. J Clin Invest 96, 1527-1534.
83. Rehermann, B., Fowler, P., Sidney, J., Person, J., Redeker, A., Brown, M., Moss, B., Sette, A. & Chisari, F. V. (1995b). The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J Exp Med 181, 1047-1058.
84. Rehermann, B., Ferrari, C., Pasquinelli, C. & Chisari, F. V. (1996a). The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-lymphocyte response. Nat Med 2, 1104-1108.
85. Rehermann, B., Lau, D., Hoofnagle, J. H. & Chisari, F. V. (1996b). Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection. J Clin Invest 97, 1655-1665.
86. Reignat, S., Webster, G. J., Brown, D. & 7 other authors (2002). Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection. J Exp Med 195, 1089-1101.
87. Rigopoulou, E. I., Suri, D., Chokshi, S., Mullerova, I., Rice, S., Tedder, R. S., Williams, R. & Naoumov, N. V. (2005). Lamivudine plus interleukin-12 combination therapy in chronic hepatitis B: antiviral and immunological activity. Hepatology 42, 1028-1036.
88. Rossol, S., Marinos, G., Carucci, P., Singer, M. V., Williams, R. & Naoumov, N. V. (1997). Interleukin- 12 induction of Th1 cytokines is important for viral clearance in chronic hepatitis B. J Clin Invest 99, 3025-3033.
89. Sakaguchi, S. (2000). Regulatory T cells: key controllers of immunologic self-tolerance. Cell 101, 455-458.
90. Seeger, C. & Mason, W. S. (2000). Hepatitis B virus biology. Microbiol Mol Biol Rev 64, 51-68.
91. Sobao, Y., Sugi, K., Tomiyama, H. & 7 other authors (2001). Identification of hepatitis B virus-specific CTL epitopes presented by HLA-A*2402, the most common HLA class I allele in East Asia. J Hepatol 34, 922-929.
92. Sobao, Y., Tomiyama, H., Sugi, K. & 7 other authors (2002). The role of hepatitis B virus-specific memory CD8 T cells in the control of viral replication. J Hepatol 36, 105-115.
93. Stoop, J. N., van der Molen, R. G., Baan, C. C., van der Laan, L. J., Kuipers, E. J., Kusters, J. G. & Janssen, H. L. (2005). Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology 41, 771-778.
94. Su, A. I., Pezacki, J. P., Wodicka, L. & 8 other authors (2002). Genomic analysis of the host response to hepatitis C virus infection. Proc Natl Acad Sci U S A 99, 15669-15674.
95. + T cell responses. J Exp Med 198, 889-901.
96. Tavakoli, S., Schwerin, W., Rohwer, A. & 9 other authors (2004). Phenotype and function of monocyte derived dendritic cells in chronic hepatitis B virus infection. J Gen Virol 85, 2829-2836.
97. Thimme, R., Chang, K. M., Pemberton, J., Sette, A. & Chisari, F. V. (2001). Degenerate inummogenicity of an HLA-A2-restricted hepatitis B virus nucleocapsid cytotoxic T-lymphocyte epitope that is also presented by HLA-B51. J Virol 75, 3984-3987.
98. Thimme, R., Bukh, J., Spangenberg, H. C., Wieland, S., Pemberton, J., Steiger, C., Govindarajan, S., Purcell, R. H. & Chisari, F. V. (2002). Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease. Proc Natl Acad Sci U S A 99, 15661-15668.
99. + T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J Virol 77, 68-76.
100. Thio, C. L., Thomas, D. L., Karacki, P. & 10 other authors (2003). Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection. J Virol 77, 12083-12087.
101. Thursz, M. R., Thomas, H. C., Greenwood, B. M. & Hill, A. V. (1997). Heterozygote advantage for HLA class-II type in hepatitis B virus infection. Nat Genet 17, 11-12.
102. Trobonjaca, Z., Leithauser, F., Moller, P., Schirmbeck, R. & Reimann, J. (2001). Activating immunity in the liver. I. Liver dendritic cells (but not hepatocytes) are potent activators of IFN-γ release by liver NKT cells. J Immunol 167, 1413-1422.
103. Tsai, S. L., Chen, P. J., Lai, M. Y., Yang, P. M., Sung, J. L., Huang, J. H., Hwang, L. H., Chang, T. H. & Chen, D. S. (1992). Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion. J Clin Invest 89, 87-96.
104. Urbani, S., Boni, C., Amadei, B., Fisicaro, P., Cerioni, S., Valli, M. A., Missale, G. & Ferrari, C. (2005). Acute phase HBV-specific T cell responses associated with HBV persistence after HBV/HCV coinfection. Hepatology 41, 826-831.
105. van der Molen, R. G., Sprengers, D., Binda, R. S., de Jong, E. C., Niesters, H. G., Kusters, J. G., Kwekkeboom, J. & Janssen, H. L. (2004). Functional impairment of myeloid and plasmacytoid dendritic cells of patients with chronic hepatitis B. Hepatology 40, 738-746.
106. Wang, F. S., Xing, L. H., Liu, M. X., Zhu, C. L., Liu, H. G., Wang, H. F. & Lei, Z. Y. (2001). Dysfunction of peripheral blood dendritic cells from patients with chronic hepatitis B virus infection. World J Gastroenterol 7, 537-541.
107. Webster, G. J., Reignat, S., Maini, M. K. & 9 other authors (2000). Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology 32, 1117-1124.
108. + T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy. J Virol 78, 5707-5719.
109. Whalley, S. A., Murray, J. M., Brown, D., Webster, G. J., Emery, V. C., Dusheiko, G. M. & Perelson, A. S. (2001). Kinetics of acute hepatitis B virus infection in humans. J Exp Med 193, 847-854.
110. Wherry, E. J., Blattman, J. N., Murali-Krishna, K., van der Most R. & Ahmed, R. (2003). Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J Virol 77, 4911-4927.
111. Wieland, S. F. & Chisari, F. V. (2005). Stealth and cunning: hepatitis B and hepatitis C viruses. J Virol 79, 9369-9380.
112. Wieland, S. F., Guidotti, L. G. & Chisari, F. V. (2000). Intrahepatic induction of alpha/beta interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice. J Virol 74, 4165-4173.
113. Wieland, S., Thimme, R., Purcell, R. H. & Chisari, F. V. (2004). Genomic analysis of the host response to hepatitis B virus infection. Proc Natl Acad Sci U S A 101, 6669-6674.
114. + T-cell immune responses during chronic viral infection. J Virol 78, 3578-3600.